Table 1 Baseline characteristics and outcomes of study populations.
Overall (n = 8217) | BLS only (n = 1201) | BLS + advanced airway (n = 5326) | BLS + advanced airway + epinephrine (n = 1690) | P-value | |
---|---|---|---|---|---|
Age, year | 65 [54–74] | 64 [53–73] | 66 [55–75] | 64 [54–73] | 0.001a,c |
Sex, female, n (%) | 2349 (28.6%) | 358 (29.8%) | 1572 (29.5%) | 419 (24.8%) | 0.001b,c |
Witnessed arrest, n (%) | 4270 (52.0%) | 741 (61.7%) | 2964 (55.7%) | 865 (51.2%) | < 0.001a,b,c |
Public place, n (%) | 1713 (20.8%) | 267 (22.2%) | 1082 (20.3%) | 364 (21.5%) | 0.247 |
Bystander CPR, n (%) | 4876 (59.3%) | 627 (52.2%) | 3161 (59.4%) | 1088 (64.4%) | < 0.001a,b,c |
Initial shockable rhythm, n (%) | 1893 (23.0%) | 332 (27.6%) | 1171 (22.0%) | 390 (23.1%) | < 0.001a |
EMS time interval, minute | |||||
Response time | 8 [7–11] | 8 [7–11] | 8 [7–11] | 9 [7–11] | < 0.001b,c |
Scene time | 14 [10–17] | 11 [9–15] | 13 [10–16] | 19 [15–24] | < 0.001a,b,c |
Transport time | 7 [5–10] | 7 [5–11] | 7 [5–9] | 7 [5–10] | 0.004a |
Total pre-hospital time | 30 [25–36] | 28 [23–35] | 29 [24–34] | 37 [31–43] | < 0.001b,c |
EMS management | |||||
Defibrillation, n (%) | 2565 (31.2%) | 426 (35.5%) | 1573 (29.5%) | 566 (33.5%) | < 0.001a,c |
Advanced airway, n (%) | 7016 (85.4%) | 0 (0%) | 5326 (100%) | 1690 (100%) | |
Endotracheal intubation, n (%) | 920 (11.2%) | 0 (0%) | 665 (12.5%) | 255 (15.1%) | < 0.001c |
SGA, n (%) | 6096 (74.2%) | 0 (0%) | 4661 (87.5%) | 1435 (84.9%) | < 0.001c |
Combitube, n (%) | 1 (0%) | 0 (0%) | 1 (0%) | 0 (0%) | |
King airway, n (%) | 53 (0.6%) | 0 (0%) | 47 (0.9%) | 6 (0.4%) | |
LMA, n (%) | 58 (0.7%) | 0 (0%) | 42 (0.8%) | 16 (0.9%) | |
I-gel, n (%) | 5984 (72.8%) | 0 (0%) | 4571 (85.8%) | 1413 (83.6%) | |
Epinephrine, n (%) | 1690 (20.6%) | 0 (0%) | 0 (0%) | 1690 (100%) | |
Pre-hospital ROSC, n (%) | 1217 (14.8%) | 262 (21.8%) | 661 (12.4%) | 294 (17.4%) | < 0.001a,b,c |
Time to prehospital ROSC, minute* | 18 [13–25] | 14 [11–20] | 17 [13–23] | 27 [21–34] | < 0.001a,b,c |
Time to ROSC, minute** | 34 [21–44] | 29 [15–41] | 34 [22–44] | 36 [26–48] | < 0.001a,b,c |
Survival outcome | |||||
Survival to discharge, n (%) | 1095 (13.3%) | 266 (22.1%) | 703 (13.2%) | 126 (7.5%) | < 0.001a,b,c |
Good neurologic recovery, n (%) | 770 (9.4%) | 205 (17.1%) | 492 (9.2%) | 73 (4.3%) | < 0.001a,b,c |